Common variable immunodeficiency: how many diseases? (Q41546330)

3 October 2017

1 reference

title

Common variable immunodeficiency: how many diseases? (English)

1 reference

common variable immunodeficiency

3 October 2017

1 reference

Spickett GP

1

1 reference

3 October 2017

Farrant J

2

1 reference

3 October 2017

North ME

3

1 reference

3 October 2017

Zhang JG

4

1 reference

3 October 2017

Morgan L

5

1 reference

3 October 2017

Webster AD

6

1 reference

3 October 2017

1 July 1997

1 reference

3 October 2017

1 reference

3 October 2017

18

1 reference

3 October 2017

325-328

1 reference

3 October 2017

7

1 reference

Primary antibody deficiency in adults

3 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Clinical and immunologic analyses of 103 patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Analysis of B cell dysfunction in patients with common variable immunodeficiency by using recombinant interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

L-selectin in patients with common variable immunodeficiency (CVID): a comparative study with normal individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

The spectrum of mutations in Btk that cause X-linked agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Females with a disorder phenotypically identical to X-linked agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Mutations in the mu heavy-chain gene in patients with agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Hyper IgM syndrome associated with defective CD40-mediated B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Family and linkage study of selective IgA deficiency and common variable immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Long-term persistence of selective IgA deficiency in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Splenic lesions in hypogammaglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Granulomatous disease in common variable immunodeficiency: effect on immunoglobulin replacement therapy and response to steroids and splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

NIH conference. New insights into common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Panhypogammaglobulinemia in systemic lupus erythematosus: in vitro demonstration of multiple cellular defects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Conversion of systemic lupus erythematosus to common variable hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

Defects in antigen-driven lymphocyte responses in common variable immunodeficiency (CVID) are due to a reduction in the number of antigen-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901086-4

7 January 2021

10.1016/S0167-5699(97)01086-4

Identifiers

DOI

1 reference

3 October 2017

1 reference